Denmark has extended its suspension of AstraZeneca vaccines for three weeks. In a statement, Denmark’s health authority noted that the EMA could not “definitively rule out” a link between the vaccine and blood clotting.
“We have started several studies and talked to experts in the affected areas, so we are sure to uncover the scope and the possible connection,” said Søren Brostrøm, director of the Danish National Board of Health.
“At present, we believe that our basis for making a final decision on the further use of the COVID-19 vaccine from AstraZeneca is too uncertain.”
“Many studies have been launched, but we do not yet have any conclusions. That is why we have decided to extend the break,” he added.